This thesis work leveraged transcriptomic and lipidomic approaches to unravel cellular and molecular mechanisms underpinning an impaired post-ischemic tissue revascularization and evaluated novel immunomodulatory nanotherapies to rescue this impairment in clinically relevant mouse models.